Stanley Jordan, United States

Director, Nephrology & Transplant Immunology, Medical Director, Kidney Transplant Program
Division of Nephrology/Kidney Transplant
Cedars Sinai Medical Center

Director, Nephrology Transplant Immunology Medical Director, Kidney Transplant Program Cedars-Sinai Medical Center and Professor of Pediatrics & Medicine David Geffen School of Medicine Los Angeles. Dr. Jordan in recognised internationally for his 3 decades of research focussing on the immunology of antibody rejection and development of novel immune modulatory therapies to combat this condition. Dr. Jordan has extensive experience with desensitization for incompatible kidney transplantation and has an active clinical trials programme examining novel therapies for desensitization and treatment of antibody-mediated rejection. He has also published novel clinical trials using complement inhibitors to prevent delayed graft function in renal allografts. Dr. Jordan and his work have been recognized by his peers and include his being the recipient of the National Kidney Foundation “Gift of Life Award” and the Distinguished Alumni Award from the University of North Carolina Chapel Hill. He was honoured with the inaugural Cedars-Sinai Prize for Research in Scientific Medicine (PRISM),conceived to recognize outstanding scientific and medical breakthroughs, the Pioneer in Medicine Award (also from Cedars-Sinai), the Award for Outstanding Achievement in Transplantation from the Transplantation Society, the Jean Hamburger Award for outstanding research in nephrology from the International Society of Nephrology and the Senior Achievement Award in Clinical Transplantation from the American Society of Transplantation. In 2020 Dr. Jordan received the Mayo Soley Award for outstanding clinical research and mentorship from the Western Society of Clinical Investigation.



© 2024 TTS 2020